The Tenaquip Foundation donation will allow for faster drug development, better care for ALS patients

 

A generous donation by The Tenaquip Foundation will improve the quality of care available to ALS patients at The Neuro, and increase the rate at which researchers can evaluate new ALS drugs.

Classified as: ALS, amyotrophic lateral sclerosis, Reed Family, Tenaquip Foundation, clinical trial unit, drug development, Angela Genge, Guy Rouleau
Published on: 3 Jul 2017
Back to top